BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2085896)

  • 1. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs.
    Yamada I; Goda T; Kawata M; Shiotuki T; Ogawa K
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3112-5. PubMed ID: 2085896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of indomethacin capsules in humans (III): Correlation with bioavailability in beagle dogs.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Nakata H; Tsutsumi J; Fujita T; Amada I
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):578-84. PubMed ID: 4077308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of indomethacin capsules in humans. (I): Bioavailability and effects of gastric acidity.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):469-74. PubMed ID: 4055157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of food on bioavailability of two indomethacin capsules containing different sizes of particles.
    Aoyagi N; Kaniwa N; Ogata H
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1338-40. PubMed ID: 2393959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of gastric acidity-controlled beagle dog to bioavailability study of cinnarizine].
    Yamada I; Goda T; Kawata M; Ogawa K
    Yakugaku Zasshi; 1990 Apr; 110(4):280-5. PubMed ID: 2376821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of single-unit commercial immediate-and sustained-release capsules compared with multiple-unit polystyrene microparticles dosage forms of indomethacin.
    Tamilvanan S; Sa B
    PDA J Pharm Sci Technol; 2008; 62(3):177-90. PubMed ID: 18661867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gastric acidity on bioavailability of N,N-dimethylcarbamoylmethylalpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetate, a new prodrug-type anti-inflammatory agent.
    Yamada I; Goda T; Kawata M; Mizuta H; Ogawa K; Yokobe T
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3372-5. PubMed ID: 2632086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentration fluctuation and bioavailability comparison between indomethacin sustained-release and conventional capsules during steady state.
    Wang JP; Liu L; Liu X; Yang XY; Li D; Ge GQ; Huang QW
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):298-301. PubMed ID: 1456047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of gastric pH on the absorption of controlled-release theophylline dosage forms in humans.
    Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Vashi VI; Hepp P; Hunt J
    Pharm Res; 1993 Jul; 10(7):1037-45. PubMed ID: 8378245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability study of commercial sustained-release preparations of diclofenac sodium in gastrointestinal physiology regulated-dogs.
    Sagara K; Nagamatsu Y; Yamada I; Kawata M; Mizuta H; Ogawa K
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3303-6. PubMed ID: 1294333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits.
    Nakajima T; Takashima Y; Iida K; Mitsuta H; Furuya A; Koishi M
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4249-54. PubMed ID: 3435949
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of gastric acidity and taste masking agent on in situ gelling pectin formulations for oral sustained delivery of acetaminophen.
    Itoh K; Kubo W; Fujiwara M; Watanabe H; Miyazaki S; Attwood D
    Biol Pharm Bull; 2006 Feb; 29(2):343-7. PubMed ID: 16462043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release of indomethacin from chitosan granules in beagle dogs.
    Miyazaki S; Yamaguchi H; Yokouchi C; Takada M; Hou WM
    J Pharm Pharmacol; 1988 Sep; 40(9):642-3. PubMed ID: 2907032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on absorption of indomethacin from sustained-release suppositories containing hydrogenated soybean lecithin in rabbits.
    Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3145-7. PubMed ID: 2632063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of zidovudine (AZT)-loaded ethylcellulose microspheres after oral administration in beagle dogs.
    Abu-Izza K; Tambrallo L; Lu DR
    J Pharm Sci; 1997 May; 86(5):554-9. PubMed ID: 9145378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
    Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sustained release on the pharmacokinetic profile of indomethacin in man.
    Yeh KC; Berger ET; Breault GO; Lei BW; McMahon FG
    Biopharm Drug Dispos; 1982; 3(3):219-30. PubMed ID: 7139063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of indomethacin capsules in humans (II): correlation with dissolution rate.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):529-34. PubMed ID: 4066077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of new indomethacin dosage forms.
    Waller ES
    Pharmacotherapy; 1983; 3(6):324-33. PubMed ID: 6361702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
    Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
    Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.